Evidence map›Paper›PMID 34449819›Full record

ArticlePloS one2021

Automated home-cage monitoring as a potential measure of sickness behaviors and pain-like behaviors in LPS-treated mice.

Hasriadi, Peththa Wadu Dasuni Wasana, Opa Vajragupta, Pornchai Rojsitthisak, Pasarapa Towiwat

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Aloifol I Derived fromACS pharmacology & translational science · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Angolensin Isolated fromInternational journal of molecular sciences · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

HasriadiFaculty of Pharmaceutical Sciences, Pharmaceutical Sciences and Technology Program, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0003-4063-3681
Peththa Wadu Dasuni WasanaFaculty of Pharmaceutical Sciences, Pharmaceutical Sciences and Technology Program, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0002-3735-799X
Opa VajraguptaFaculty of Pharmaceutical Sciences, Research Affairs, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0003-3313-0621
Pornchai RojsitthisakNatural Products for Ageing and Chronic Diseases Research Unit, Chulalongkorn University, Bangkok, Thailand.
Pasarapa TowiwatNatural Products for Ageing and Chronic Diseases Research Unit, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0001-9394-4622

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of endotoxin, such as lipopolysaccharide (LPS) as a model of sickness behavior, has attracted recent attention. To objectively investigate sickness behavior along with its pain-like behaviors in LPS-treated mice, the behavioral measurement requires accurate methods, which reflects clinical relevance. While reflexive pain response tests have been used for decades for pain assessment, its accuracy and clinical relevance remain problematic. Hence, we used automated home-cage monitoring LABORAS to evaluate spontaneous locomotive behaviors in LPS-induced mice. LPS-treated mice displayed sickness behaviors including pain-like behaviors in automated home-cage monitoring characterized by decreased mobile behaviors (climbing, locomotion, rearing) and increased immobility compared to that of the control group in both short- and long-term locomotive assessments. Here, in short-term measurement, both in the open-field test and automated home-cage monitoring, mice demonstrated impaired locomotive behaviors. We also assessed 24 h long-term locomotor activity in the home-cage system, which profiled the diurnal behaviors of LPS-stimulated mice. The results demonstrated significant behavioral impairment in LPS-stimulated mice compared to the control mice in both light and dark phases. However, the difference is more evident in the dark phase compared to the light phase owing to the nocturnal activity of mice. In addition, the administration of indomethacin as a pharmacological intervention improved sickness behaviors in the open-field test as well as automated home-cage monitoring, confirming that automated home-cage monitoring could be potentially useful in pharmacological screening. Together, our results demonstrate that automated home-cage monitoring could be a feasible alternative to conventional methods, such as the open-field test and combining several behavioral assessments may provide a better understanding of sickness behavior and pain-like behaviors in LPS-treated mice.

Indexed as

Monitoring, PhysiologicAnimalsAnxietyBehavior, AnimalDisease Models, AnimalHumansIllness BehaviorLipopolysaccharidesLocomotionMiceMotor ActivityPainPain MeasurementLipopolysaccharides

Identifiers

PMID34449819
PMCPMC8396795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.